Mini-Reviews in Medicinal Chemistry

Last updated

Abstracting and indexing

The journal is abstracted and indexed in:

According to the Journal Citation Reports , the journal has a 2020 impact factor of 3.862. [2] [3]

Controversy concerning Mini-Reviews in Medicinal Chemistry

Mini-Reviews in Medicinal Chemistry employs peer review, [4] however, several scientists have raised concerns about whether it is a predatory journal after being invited to review articles or serve as an editor in areas where they have no scientific expertise. [5] [6]

Related Research Articles

<span class="mw-page-title-main">Hindawi (publisher)</span> Scientific and medical journal publisher

Hindawi is a publisher of peer-reviewed, open access, scientific journals currently active in scientific, technical, and medical (STM) literature. It was founded in 1997 in Cairo, Egypt, and purchased in 2021 for $298 million by John Wiley & Sons, a large US-based publishing company. The publisher has been classified as a predatory publisher. After almost 10,000 article retractions in 2023, Wiley announced that it would cease using the Hindawi brand.

MDPI is a publisher of open-access scientific journals. It publishes over 390 peer-reviewed, open access journals. MDPI is among the largest publishers in the world in terms of journal article output, and is the largest publisher of open access articles.

<i>Current Pharmaceutical Design</i> Academic journal

Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field.

World Journal of Gastroenterology is a weekly peer-reviewed open access medical journal that covers research in gastroenterology. It was established in 1995 and is published by Baishideng Publishing Group, which was included on Beall's list of predatory publishers. The editor-in-chief is Andrzej S. Tarnawski.

<span class="mw-page-title-main">Bentham Science Publishers</span> Academic publishing company

Bentham Science Publishers is a company that publishes scientific, technical, and medical journals and e-books. It publishes over 120 subscription-based academic journals and around 40 open access journals.

<i>MedChemComm</i> Academic journal

MedChemComm is a peer-reviewed scientific journal publishing original (primary) research and review articles on all aspects of medicinal chemistry, including drug discovery, pharmacology and pharmaceutical chemistry. Until December 2019, it was published monthly by the Royal Society of Chemistry in partnership with the European Federation for Medicinal Chemistry, of which it was the official journal. Authors can elect to have accepted articles published as open access. According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.495, ranking it 27th out of 59 journals in the category "Chemistry, Medicinal" and 163 out of 289 journals in the category "Biochemistry & Molecular Biology".

Current Molecular Medicine is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Andras Guttman. The journal covers research on molecular mechanisms of disease pathogenesis, the development of molecular diagnosis, and/or novel approaches to rational treatment. Formats of publication include original research reports, review papers, and rapid communications ("letters").

Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Liang Cheng. The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters").

Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang. The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters").

Current Medicinal Chemistry is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Atta-ur-Rahman, FRS. The journal covers developments in medicinal chemistry and rational drug design and publishes original research reports and review papers.

<i>Current Topics in Medicinal Chemistry</i> Academic journal

Current Topics in Medicinal Chemistry is a biweekly peer-reviewed medical journal published by Bentham Science Publishers. It includes review articles on all aspects of medicinal chemistry, including drug design. The current editor-in-chief is Jia Zhou.

Frontiers Media SA is a publisher of peer-reviewed, open access, scientific journals currently active in science, technology, and medicine. It was founded in 2007 by Kamila and Henry Markram. Frontiers is based in Lausanne, Switzerland, with other offices in the United Kingdom, Spain, and China. In 2022, Frontiers employed more than 1,400 people, across 14 countries. All Frontiers journals are published under a Creative Commons Attribution License.

<span class="mw-page-title-main">Predatory publishing</span> Fraudulent business model for scientific publications

Predatory publishing, also write-only publishing or deceptive publishing, is an exploitative academic publishing business model that involves charging publication fees to authors while only superficially checking articles for quality and legitimacy, and without providing editorial and publishing services that legitimate academic journals provide, whether open access or not. The rejection rate of predatory journals is low, but seldom zero. The phenomenon of "open access predatory publishers" was first noticed by Jeffrey Beall, when he described "publishers that are ready to publish any article for payment". However, criticisms about the label "predatory" have been raised. A lengthy review of the controversy started by Beall appears in The Journal of Academic Librarianship.

Combinatorial Chemistry & High Throughput Screening is a peer-reviewed scientific journal that covers combinatorial chemistry. It was established in 1998 and is published by Bentham Science Publishers. The editor-in-chief is Gerald H. Lushington. The journal has 5 sections: Combinatorial/ Medicinal Chemistry, Chemo/Bio Informatics, High Throughput Screening, Pharmacognosy, and Laboratory Automation.

Future Medicinal Chemistry is a peer-reviewed medical journal covering all aspects of medicinal chemistry, including drug discovery, pharmacology, in silico drug design, structural characterization techniques, ADME-Tox investigations, and science policy, economic and intellectual property issues. It was established in 2009 and is published by Future Science. The editors-in-chief are Iwao Ojima and Jonathan Baell.

Aging is a bimonthly peer-reviewed open access bio-medical journal covering research on all aspects of gerontology. The journal was established in 2009 and is published by Impact Journals. The editors-in-chief are Jan Vijg, David Andrew Sinclair, Vera Gorbunova, Judith Campisi, Mikhail V. Blagosklonny.

The Emerging Sources Citation Index (ESCI) is a citation index produced since 2015 by Thomson Reuters and now by Clarivate. According to the publisher, the index includes "peer-reviewed publications of regional importance and in emerging scientific fields".

<i>Letters in Organic Chemistry</i> Academic journal

Letters in Organic Chemistry, is a peer-reviewed monthly scientific journal, published since 2004 by Bentham Science Publishers. Letters in Organic Chemistry is indexed in: Chemical Abstracts Service (CAS), EBSCOhost, British Library, PubMed, Web of Science, and Scopus.

Anti-Cancer Agents in Medicinal Chemistry is a peer-reviewed academic journal covering the disciplines of medicinal chemistry and drug design relating to chemotherapeutic agents in cancer. It is published by Bentham Science Publishers and the editor-in-chief is Simone Carradori. The journal covers developments in "medicinal chemistry and rational drug design for the discovery of anti-cancer agents" and publishes original research reports and review papers.

Juniper Publishers is a publisher of various academic journals. It has a postal address in Irvine, California, USA, located in a residential neighborhood but has employees in Hyderabad, India. Juniper Publishers has been included on Beall's List of potential predatory open-access publishers, and has faced other criticisms of its publishing practices.

References

  1. "Mini-Reviews in Medicinal Chemistry". Bentham Science. Retrieved 17 June 2021.
  2. "Journals Ranked by Impact: Chemistry, Medicinal". 2020 Journal Citation Reports (Science ed.). Clarivate. 2021.{{cite book}}: |work= ignored (help)
  3. Press Release ::: JOURNAL CITATION REPORTSTM 2021 - A SIGNIFICANT INCREASE IN IMPACT FACTOR RATINGS FOR BENTHAM SCIENCE JOURNALS
  4. "Mini-Reviews in Medicinal Chemistry Home Page". Bentham Science Publishers Ltd. Retrieved 2021-06-17.
  5. "Predatory or Not?". Word Press. 7 January 2020. Retrieved 17 June 2021.
  6. "Bentham wants me as reviewer ... or medicinal chemistry". Blogspot. Retrieved 17 June 2021.